A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

Clinical trial NCT00912288 · TERMINATED

Trial details

NCT number: NCT00912288
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2009-09-01
Primary completion: 2010-08-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.